Nov 2, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018 |
Aug 3, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018 |
Jul 31, 2018 |
|
Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management |
Jun 5, 2018 |
|
Results of Annual General Meeting of Shareholders Held May 31, 2018 |
Apr 30, 2018 |
|
Notice of Annual General Meeting and Explanatory Memorandum |
Apr 27, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended March 31, 2018 and Reports 2017 Full Year Financial Results |
Feb 22, 2018 |
|
Results of General Meeting of Shareholders Held February 22, 2018 |
Jan 11, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Nine Months Ended September 30, 2017; Board and Senior Management Changes; Strategic Review of Development Pipeline Including Zydax Canine and 2018 Guidance |
Jan 11, 2018 |
|
Notice of General Meeting and Explanatory Memorandum |
Jan 4, 2018 |
|
Parnell Appoints Tony G Hartnell AM to Board of Directors |
Jan 3, 2018 |
|
Results of General Meeting of Shareholders held December 29, 2017 |
Nov 21, 2017 |
|
Notice of Annual General Meeting and Explanatory Memorandum |
Aug 17, 2017 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017 |
May 24, 2017 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results Update |
May 18, 2017 |
|
Parnell to Report Business Update for the Three Months Ended March 31, 2017 on May 24, 2017 |
Apr 28, 2017 |
|
Notice of Annual General Meeting and Explanatory Memorandum |
Mar 21, 2017 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2016 |
Feb 27, 2017 |
|
UPDATED: Parnell to Report Financial Results for Fiscal Year 2016 on March 21, 2017 |
Feb 23, 2017 |
|
Parnell to Report Financial Results for Fiscal Year 2016 on March 22, 2017 |
Dec 19, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ |
Dec 9, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market |
Dec 9, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market |
Nov 22, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility |
Nov 2, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016 |
Oct 27, 2016 |
|
Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016 |
Aug 4, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016 |
Jul 26, 2016 |
|
Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016 |
Jul 26, 2016 |
|
Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016 |
May 31, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial |
May 12, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock |
Apr 22, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update |
Apr 18, 2016 |
|
Parnell to Report Business Results for the Three Months Ended March 31, 2016 on April 22, 2016 |
Mar 31, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies Animal Health Summit |
Feb 24, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015 |
Feb 18, 2016 |
|
Parnell to Report Financial Results for Fiscal Year 2015 on February 24, 2016 |
Jan 20, 2016 |
|
UPDATE — Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Capital Fund to Purchase Ordinary Shares |
Jan 19, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Captial Fund to Purchase Ordinary Shares |
Jan 11, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference in San Francisco |
Dec 17, 2015 |
|
Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors |
Dec 17, 2015 |
|
Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors |
Nov 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Global Healthcare Conference in London |
Oct 21, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Third Quarter Business Results |
Oct 9, 2015 |
|
Parnell to Report Financial Results for the Nine Months Ended September 30, 2015 on October 21, 2015 |
Oct 9, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Restructures Board |
Sep 28, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Ladenburg Thalmann 2015 Healthcare Conference |
Aug 11, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2015 |
Aug 10, 2015 |
|
Parnell Appoints Peter A. Croden to Board of Directors |
Jul 29, 2015 |
|
Parnell to Report Financial Results for the Six Months Ended June 30, 2015 on August 11, 2015 |
Jun 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Investor Day Highlights |
Jun 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces $11 Million Secured Term Loan Facility |
Jun 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Positive Top-Line Pivotal Trial Results for Zydax(R), Disease-Modifying Osteoarthritis Drug in Dogs |
Jun 8, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Participate in Two Upcoming Investor Conferences |
May 20, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Healthcare Conference |
Apr 22, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results |
Apr 13, 2015 |
|
Parnell to Discuss First Quarter Business Performance on April 22, 2015 |
Mar 9, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit |
Feb 25, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended December 31, 2014 |
Jan 12, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference |
Dec 19, 2014 |
|
Parnell Management Adopts 10b5-1 Trading Plans |
Dec 9, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility |
Dec 9, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End |
Nov 12, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences |
Sep 15, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Fiscal Year 2014 Financial Results |
Sep 10, 2014 |
|
Parnell to Report Fiscal Year 2014 Financial Results September 15, 2014 |
Sep 8, 2014 |
|
Parnell Appoints US-Based Independent Directors Phyllis Gardner, M.D., and David L. Greenwood to Its Board of Directors |
Sep 3, 2014 |
|
Parnell Announces Results From the Successful Efficacy Study for Zydax(R) |
Jul 24, 2014 |
|
Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration |
Jun 18, 2014 |
|
Parnell Pharmaceuticals (NASDAQ: PARN) to Ring The NASDAQ Stock Market Opening Bell in Celebration of IPO |
May 21, 2014 |
|
Parnell Pharmaceuticals Files Registration for Proposed Initial Public Offering |
Feb 25, 2013 |
|
Parnell Launches Synchronization Pack™ |
Aug 1, 2009 |
|
Australian Veterinary Pharmaceuticals Company Opens World Class Manufacturing Facility |